CORRECTION article
Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Correction: Unveiling the NEFH+ malignant cell subtype: Insights from single-cell RNA sequencing in prostate cancer progression and tumor microenvironment interactions
Provisionally accepted- 1Department of Urology, The Second People’s Hospital of Meishan City, Meishan, Sichuan, China
- 2Department of Urology, China-Japan Union Hospital of Jilin University, Changchun, China
- 3Shandong University of Traditional Chinese Medicine, Jinan, China
- 4China Institute of Sport and Health Science, Beijing Sport University, Beijing, China
- 5Department of Urology, The First People’s Hospital of Jiangxia District, Wuhan, Hubei, China
- 6Department of Urology, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Keywords: multi-omics, single-cell RNA sequencing, prostate cancer, tumor heterogeneity, precision medicine, Drug Discovery
Received: 03 Oct 2025; Accepted: 24 Oct 2025.
Copyright: © 2025 Wang, Zhao, Zhang, Sun, Zhikai, Wang, Liu and Yu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Fu Zhao, r747757207@163.com
Changzhong Wang, wangczky@163.com
Yan Liu, rliuyan@foxmail.com
Zongze Yu, yuzongze202303@163.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
